HF
ARMP icon

HRT Financial’s Armata Pharmaceuticals ARMP Stock Holding History

HRT Financial’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Buy
+10,595
New +$89.2K ﹤0.01% 3341
2023
Q3 		– Sell
-19,742
Closed -$22K – 2375
2023
Q2 		$22K Sell
19,742
-11,452
-37% -$16.6K ﹤0.01% 2086
2023
Q1 		$52K Sell
31,194
-11,083
-26% -$25.7K ﹤0.01% 2123
2022
Q4 		$52K Buy
+42,277
New +$110K ﹤0.01% 2115

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's ARMP Position: Q1 2026 in Review

HRT Financial opened a new position in Armata Pharmaceuticals (ARMP) in Q1 2026: 10,595 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3341 among its holdings. This is a return to the name: HRT Financial previously reported a position in ARMP as recently as Q2 2023.

HRT Financial first reported a position in ARMP in Q4 2022 and has held it in 4 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • HRT Financial held 10,595 shares of Armata Pharmaceuticals worth $108K as of Q1 2026.
  • Armata Pharmaceuticals was a new HRT Financial position in Q1 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3341 holding.
  • HRT Financial first reported a position in Armata Pharmaceuticals in Q4 2022 and has held it in 4 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.